Target Price | CHF734.46 |
Price | CHF829.00 |
Deviation | 11.40% |
Number of Estimates | 13 |
13 Analysts have issued a price target Swiss Life 2026 . The average Swiss Life target price is CHF734.46. This is 11.40% lower than the current stock price. The highest price target is CHF809.00 2.41% , the lowest is CHF575.00 30.64% . | |
A rating was issued by 15 analysts: 5 Analysts recommend Swiss Life to buy, 5 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Swiss Life stock has an average upside potential 2026 of 11.40% . |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 15.28 | 17.75 |
0.28% | 16.19% | |
Net Margin | 7.92% | 7.27% |
13.94% | 8.20% |
4 Analysts have issued a sales forecast Swiss Life 2025 . The average Swiss Life sales estimate is CHF17.8b . This is 16.19% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.2b 38.51% , the lowest is CHF8.9b 41.49% .
This results in the following potential growth metrics:
2024 | CHF15.3b | 0.28% |
---|---|---|
2025 | CHF17.8b | 16.19% |
2026 | CHF18.2b | 2.28% |
2027 | CHF21.2b | 16.98% |
2028 | CHF22.4b | 5.65% |
9 Swiss Life Analysts have issued a net profit forecast 2025. The average Swiss Life net profit estimate is CHF1.3b . This is 6.02% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.4b 12.23% , the lowest is CHF1.2b 1.48% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.2b | 14.25% |
---|---|---|
2025 | CHF1.3b | 6.72% |
2026 | CHF1.4b | 6.59% |
2027 | CHF1.5b | 6.53% |
2028 | CHF1.7b | 12.67% |
2024 | 7.92% | 13.94% |
---|---|---|
2025 | 7.27% | 8.20% |
2026 | 7.58% | 4.26% |
2027 | 6.90% | 8.97% |
2028 | 7.36% | 6.67% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 42.41 | 45.26 |
14.25% | 6.72% | |
P/E | 18.32 | |
EV/Sales | 1.87 |
9 Analysts have issued a Swiss Life forecast for earnings per share. The average Swiss Life EPS is CHF45.26 . This is 6.02% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF47.91 12.23% , the lowest is CHF43.32 1.48% .
This results in the following potential growth metrics and future valuations:
2024 | CHF42.41 | 14.25% |
---|---|---|
2025 | CHF45.26 | 6.72% |
2026 | CHF48.24 | 6.58% |
2027 | CHF51.39 | 6.53% |
2028 | CHF57.90 | 12.67% |
Current | 19.42 | 12.00% |
---|---|---|
2025 | 18.32 | 5.66% |
2026 | 17.18 | 6.22% |
2027 | 16.13 | 6.11% |
2028 | 14.32 | 11.22% |
Based on analysts' sales estimates for 2025, the Swiss Life stock is valued at an EV/Sales of 1.87 and an P/S ratio of 1.33 .
This results in the following potential growth metrics and future valuations:
Current | 2.17 | 1.81% |
---|---|---|
2025 | 1.87 | 13.93% |
2026 | 1.83 | 2.22% |
2027 | 1.56 | 14.52% |
2028 | 1.48 | 5.35% |
Current | 1.55 | 1.68% |
---|---|---|
2025 | 1.33 | 13.94% |
2026 | 1.30 | 2.22% |
2027 | 1.11 | 14.52% |
2028 | 1.05 | 5.34% |
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Feb 05 2025 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Dec 12 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Dec 08 2024 |
HSBC |
Hold
➜
Hold
|
Unchanged | Nov 24 2024 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Feb 05 2025 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Dec 12 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Dec 08 2024 |
Unchanged
HSBC:
Hold
➜
Hold
|
Nov 24 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.